ENETS Guidelines Neuroendocrinology 2004;80:394–424 DOI: [removed] Published online: April 18, 2005

First Page		Document Content
Date: 2012-06-18 21:28:45 Endocrine system Digestive system Neuroendocrine tumor Gastrointestinal cancer Insulinoma Zollinger–Ellison syndrome Multiple endocrine neoplasia type 1 Multiple endocrine neoplasia Pituitary adenoma Medicine Oncology Neuroendocrinology		ENETS Guidelines Neuroendocrinology 2004;80:394–424 DOI: [removed] Published online: April 18, 2005 Add to Reading List Source URL: www.carcinoid.org Download Document from Source Website File Size: 252,43 KB Share Document on Facebook

	“New Paradigms That Increase Survival in Neuroendocrine Tumor Patients” Eugene A. Woltering MD FACS NOLANETSZEBRA = office DocID: 1v5gL - View Document
	ORIGINAL ARTICLE Clinical Value of Monitoring Plasma Octreotide Levels During Chronic Octreotide Long-Acting Repeatable Therapy in Carcinoid Patients Eugene A. Woltering, MD, FACS,* Vergilio A. Salvo, MD,* Thomas M. O_D DocID: 1rlNJ - View Document
	J. Vet. Med. A 36, 1989 Paul Parey Scientific Publishers, Berlin and Hamburg ISSN184X Department of Veterinary Pathology2, University of Utrecht, The Netherlands, Department of Veterinary Patholo DocID: 1r81K - View Document
	ORIGINAL ARTICLE Validation of Neurokinin A Assays in the United States and Europe Paris Mamikunian,* Joy E. Ardill, PhD,Þ Thomas M. O’Dorisio, MD,þ Siegfried R. Krutzik, PhD,* Aaron I. Vinik, MD, PhD,§ Vay Liang W DocID: 1r2MN - View Document
	JOBNAME: pan 31#PAGE: 1 OUTPUT: Wednesday October 19 08:24:lww/panMPA200087 ORIGINAL ARTICLE Effect of Octreotide LAR Dose and Weight on Octreotide DocID: 1qMJM - View Document